胃肠道癌症的CAR-T疗法:目前的状况,挑战和未来的方向
Weidong Li1, Yueming Huang1, Xinhao Zhou1
1Department of Gastrointestinal Surgery, Zhongshan City People's Hospital, Zhongshan, Guangdong, China.
概括
化学抗原受体 (CAR) T细胞疗法对胃肠道癌症有希望,但面临挑战. 正在开发创新策略,以克服这些障碍,并推进对固体瘤的CAR-T疗法.
科学领域:
- 免疫学 免疫学 免疫学
- 在瘤学瘤学.
- 生物技术是生物技术.
背景情况:
- 化学抗原受体 (CAR) T细胞疗法对血液癌症有效.
- 它在固体瘤,特别是胃肠道 (GI) 癌症中的使用受抗原选择,瘤微环境复杂性和毒性限制.
- 胃肠道癌包括食道癌,胃癌,结直肠癌,胰腺癌和肝癌.
研究的目的:
- 审查在肠道癌症中CAR-T治疗的现状.
- 讨论应用CAR-T疗法对固体瘤的挑战和局限性.
- 突出用于推进胃肠道癌症CAR-T治疗的创新策略.
主要方法:
- 对当前在肠道癌症中进行的CAR-T疗法研究的文献综述.
- 分析挑战,包括目标抗原识别和瘤微环境.
- 探索新的CAR-T策略,如多种类型和装甲CAR-T细胞.
主要成果:
- 卡特-T疗法已经显示出潜力,但在肠道癌症中面临重大障碍.
- 关键的挑战包括识别合适的瘤抗原和克服免疫抑制瘤微环境.
- 新的方法如多种特异性的CAR-T细胞和装甲的CAR-T细胞正在出现.
结论:
- 对于肠道癌的CAR-T疗法的进步需要解决目前的局限性.
- 创新策略对于提高实体瘤的疗效和安全性至关重要.
- 需要进一步的研究才能充分实现CAR-T治疗在治疗胃肠道恶性瘤方面的潜力.
更多相关视频
09:56A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy
Published on: February 21, 2025
464
08:46A Real-time Potency Assay for Chimeric Antigen Receptor T Cells Targeting Solid and Hematological Cancer Cells
Published on: November 12, 2019
53.2K
相关概念视频
Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
Tumor Immunotherapy
488
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
488
Cancer Therapies
7.6K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.6K
Cancer Vaccines
342
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
342
